Preparation and preliminary application of anti-human breast cancer MUC1 monoclonal antibody

李航,袁时芳,凌瑞,贠军,李永平,王辉,李郁,宋朝君,刘佩娟

DOI: https://doi.org/10.3760/cma.j.issn.1007-631X.2015.06.016

2015-01-01

Abstract:Objective To prepare the anti-human MUC1 monoclonal antibody (mAb) and to apply it in human breast cancer tissues,fibro adenoma,cystic hyperplasia and normal breast tissues,using immunohistochemistry assay.Methods Synthetic MUC1 repetitive sequence short peptide coupled with KLH protein and BSA protein as antigen to immunize Balb/c mice,cell lines capable of secreting monoclonal antibodies were screened by hybridoma cell fusion technique.The specificities and subclasses of the prepared monoclonal antibodies were identified and analyzed by ELISA,Western blot,flow cytometry and immunofluorescence test.The antibodies were used in the detection of clinical human breast cancer,benign fibro adenoma and normal breast tissue by immunohistochemical methods.Results Four hibridoma cell lines secreting specific anti-MUC1 mAbs were obtained,The titers of the most powerful antibody were above 1 ∶ 107.3 strains were of IgG1 antibody,one was of IgM,and the light chain of which was categorized into chain to.The mAb could specifically bind to the MCF-7 cells,which was verified by Western blot,flow cytometry analysis,fluorescence immunoassay and immunohistochemistry test.Significant differences of expression (all P ＜ 0.01) of the detection of MUC1 monoclonal antibodies were found in breast cancer tissue,fibro adenoma,cystic hyperplasia and normal breast tissues.Conclusions The mAb against MUC1 developed in this study is of high titers and specific for breast cancer,exhibiting a favourable prospect for early diagnosis and targeted therapy of breast cancer.